Alexandros D Tselepis Selected Research

1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)

9/2014	Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases.
8/2014	Visceral leishmaniasis is associated with marked changes in serum lipid profile.
1/2014	Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A₂ (Lp-PLA₂) bound to LDL and HDL.
11/2012	Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
10/2012	Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
8/2012	Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.
11/2010	Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia.
9/2009	Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.
5/2009	The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
10/2007	New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandros D Tselepis Research Topics

Disease

25	Atherosclerosis 01/2021 - 12/2002
25	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2002
17	Inflammation (Inflammations) 01/2021 - 12/2002
16	Acute Coronary Syndrome 01/2020 - 03/2004
16	Dyslipidemias (Dyslipidemia) 05/2015 - 02/2002
12	Thrombosis (Thrombus) 01/2019 - 02/2004
9	Hemorrhage 01/2021 - 02/2006
9	Hypercholesterolemia 03/2015 - 02/2002
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 12/2002
6	Ischemic Stroke 01/2022 - 07/2006
5	Diabetes Mellitus 01/2021 - 03/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 03/2005
5	Hyperlipidemias (Hyperlipidemia) 03/2009 - 07/2005
4	Hypertension (High Blood Pressure) 01/2021 - 06/2011
4	Myocardial Infarction 01/2021 - 03/2017
4	Rheumatoid Arthritis 05/2018 - 01/2006
4	Hypertriglyceridemia 01/2016 - 10/2004
4	Chronic Renal Insufficiency 01/2014 - 07/2005
3	Stroke (Strokes) 01/2021 - 07/2006
3	Neoplasms (Cancer) 01/2019 - 02/2012
3	Peripheral Arterial Disease 01/2018 - 10/2007
3	Insulin Resistance 01/2017 - 01/2007
3	Overweight 01/2016 - 01/2012
3	Coronary Disease (Coronary Heart Disease) 03/2015 - 12/2002
3	Prediabetic State (Prediabetes) 01/2015 - 06/2011
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2012 - 10/2006
3	Vascular Diseases (Vascular Disease) 05/2008 - 05/2007
3	Essential Hypertension 01/2007 - 06/2004
2	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 02/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2012
2	Proteinuria 01/2021 - 01/2004
2	Crohn Disease (Crohn's Disease) 01/2016 - 09/2014
2	Ulcerative Colitis 01/2016 - 09/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 09/2014
2	Necrosis 08/2014 - 10/2009
2	Infections 08/2014 - 10/2011
2	Death (Near-Death Experience) 01/2014 - 11/2012
2	Wounds and Injuries (Trauma) 03/2012 - 02/2012
2	Carotid Artery Thrombosis 01/2011 - 05/2009
2	Carotid Artery Diseases 11/2010 - 10/2006

Drug/Important Bio-Agent (IBA)

27	oxidized low density lipoproteinIBA 01/2021 - 02/2002
21	LipidsIBA 01/2021 - 12/2002
21	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 09/2014 - 12/2002
19	Lipoproteins (Lipoprotein)IBA 01/2016 - 02/2002
15	LDL CholesterolIBA 01/2021 - 02/2002
14	EnzymesIBA 01/2015 - 02/2002
11	Rosuvastatin Calcium (Crestor)FDA Link 05/2015 - 07/2007
10	Clopidogrel (Plavix)FDA Link 01/2021 - 03/2004
10	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2006
10	Lipoprotein(a)IBA 08/2014 - 04/2003
9	CholesterolIBA 01/2017 - 07/2006
8	HDL LipoproteinsIBA 01/2015 - 05/2005
7	HDL CholesterolIBA 01/2021 - 07/2006
7	LDL Lipoproteins (beta Lipoproteins)IBA 05/2018 - 07/2006
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 10/2007
7	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014 - 12/2002
7	Platelet Activating FactorIBA 05/2005 - 02/2002
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 02/2006
6	AutoantibodiesIBA 05/2018 - 08/2006
6	ApolipoproteinsIBA 01/2017 - 07/2006
6	Ezetimibe (Zetia)FDA Link 01/2017 - 10/2007
6	Simvastatin (Zocor)FDA LinkGeneric 03/2015 - 03/2011
6	Atorvastatin (Lipitor)FDA Link 03/2015 - 02/2002
6	Fenofibrate (CiL)FDA LinkGeneric 04/2012 - 05/2003
5	Fibrinogen (Factor I)FDA Link 01/2021 - 02/2004
5	CytokinesIBA 08/2014 - 12/2002
5	Phospholipases (Phospholipase)IBA 12/2013 - 12/2002
5	1-penicillamyl-Leu(2)- oxytocinIBA 08/2012 - 12/2002
4	Apolipoproteins B (ApoB)IBA 01/2021 - 12/2003
4	C-Reactive ProteinIBA 01/2021 - 12/2011
4	AntibodiesIBA 05/2018 - 10/2006
4	AdipokinesIBA 01/2016 - 01/2008
4	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 05/2007
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2009
3	Peptide Hydrolases (Proteases)FDA Link 11/2019 - 11/2017
3	Purinergic P2Y Receptor AntagonistsIBA 01/2019 - 11/2017
3	Aryldialkylphosphatase (Paraoxonase)IBA 08/2014 - 05/2007
3	Apolipoproteins AIBA 08/2014 - 07/2006
3	IntegrinsIBA 05/2009 - 02/2004
3	We 201IBA 10/2006 - 12/2002
3	Apoprotein(a) (Apolipoprotein (a))IBA 07/2006 - 04/2003
3	Protein Isoforms (Isoforms)IBA 07/2006 - 04/2003
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 12/2003
2	SaltsIBA 01/2020 - 01/2014
2	AntigensIBA 05/2018 - 08/2006
2	Cyclooxygenase 1IBA 01/2018 - 11/2017
2	AdiponectinIBA 01/2016 - 10/2009
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014 - 02/2012
2	Interleukin-6 (Interleukin 6)IBA 12/2012 - 02/2012
2	LipopolysaccharidesIBA 12/2012 - 12/2010
2	HydrogenIBA 10/2012 - 02/2012
2	Sulfates (Sulfates, Inorganic)IBA 10/2012 - 02/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012 - 10/2009
2	Peptides (Polypeptides)IBA 01/2011 - 05/2009
2	Hemostatics (Antihemorrhagics)IBA 01/2011 - 05/2009
2	Adenosine Diphosphate (ADP)IBA 01/2011 - 08/2005

Therapy/Procedure

19	Therapeutics 07/2021 - 12/2003
5	Secondary Prevention 01/2019 - 01/2017
2	Fat-Restricted Diet (Diet, Fat Restricted) 01/2017 - 01/2016
2	Colectomy 07/2013 - 02/2012